Venture Capital Investors

Owkin

Owkin is a VC investing group that backs technology-based companies.

Venture Investor Overview

Contact Information

Background Information

Overview

Owkin is an AI Biotech that uses AI to unlock complex biology to find the right treatment for every patient. Owkin was founded by Thomas Clozel, MD, a clinical research doctor and former assistant professor in clinical onco-hematology, and Gilles Wainrib, PhD, a pioneer in the field of machine learning in biology, in 2016. We use AI to identify new drug candidates, de-risk and accelerate clinical trials, and build diagnostic solutions that improve patient outcomes.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

6/26/2024

Transaction History

Our records indicate that Owkin invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Investor Contacts

Title

Name

Email & Social

Chief Executive Officer

Thomas Clozel

        

Chief Marketing Officer

Darius Meadon

        

Funds

No fund closings have been recorded for this company.

Portfolio Companies

Owkin has invested in the companies below, according to our database records. If we are missing a portfolio company, please let us know.

Browse more venture capital investors:

OVP Venture Partners | Owl Capital

Share this article

About Our VC & M&A Database

This VC firm profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary